The short answer: probably not, unless the B6 dose is high
The FDA cannot verify the quality, safety, or effectiveness of these non-FDA-approved compounded GLP-1 products Entities engaged in mass marketing should be on notice. FDA Press Announcement In regulatory language, the agency also made clear that compounded products cannot be marketed as generic, clinically proven, or equivalent to approved drugs
Presented for research literature review only Gibbs JP et al
Murohara T, Ikeda H, Katoh A, Takajo Y, Otsuka Y, Haramaki N, Imaizumi T (2002) Vitamin E inhibits lysophosphatidylcholine-induced endothelial dysfunction and platelet activation
G6PD deficiency, PK deficiency, and other erythrocyte enzymatic defects